How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | TEMTempus AI, Inc. | MEDPMedpace Holdings, Inc. | RVTYREVVITY, INC. | CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Median of the restexcluding TEM |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $63.81▼ 3.95 (5.83%) | $662.48▲ 40.05 (6.43%) | $156.61▲ 0.60 (0.38%) | $344.87▲ 29.42 (9.33%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 4.7/10 | 7.3/10 | 6.0/10 | 2.0/10 | 6.0/10 |
| Market value | $12.23B | $18.80B | $17.58B | $16.97B | |
| Revenue | $1.27B | $2.53B | $2.86B | $4.02B | |
| Profit | -$245.0M | $451.1M | $241.2M | -$144.3M | |
| Revenue growthChange in sales versus the prior year. | 83.4% | 20.0% | 3.7% | -0.9% | 3.7% |
| Gross marginShare of sales left after the direct cost of producing them. | — | — | — | — | — |
| Operating marginShare of sales left after running the business, before interest and tax. | -19.9% | 21.1% | 12.5% | 0.6% | 12.5% |
| Profit marginProfit kept from each dollar of sales. | -19.3% | 17.8% | 8.4% | -3.6% | 8.4% |
| Free cash flow marginCash left after capital spending, as a share of sales. | -18.8% | 26.9% | 17.8% | 12.9% | 17.8% |
| Return on equityProfit against the owners' stake in the company. | -49.9% | 98.3% | 3.3% | -4.6% | 3.3% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | — | — | 3.4% | 0.4% | 1.9% |
| P/E ratioPrice paid per dollar of annual profit. | — | 41.66x | 72.90x | — | 57.28x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | — | 26.10x | 44.10x | 35.10x |
| Price to book | 24.88x | 40.94x | 2.43x | 5.36x | 5.36x |
| Debt to equityTotal liabilities compared with owners' stake. | 3.63x | 3.30x | 0.68x | 1.24x | 1.24x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 3/7 | 6/7 | 6/8 | 4/8 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | distress | distress | safe | grey |
How TEM compares with the others
- TEM's operating margin of -19.9% is lower than the median of the other companies selected (12.5%).
- Its revenue grew faster than the median of the other companies selected: 83.4% against 3.7%.
- It has no P/E to set against theirs, because it did not make a profit.
- Its liabilities are higher relative to equity than the median of the other companies selected: 3.6x against 1.2x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.